Nutromics
Developer of a wearable, microneedle-enabled platform for continuous, real-time molecular monitoring. The company combines electrochemical aptamer-based (DNA) sensors with microneedle and hydrogel technologies to measure drugs, proteins, metabolites and biomarkers in interstitial fluid and stream results via Bluetooth for clinical use. Primary near-term application focus includes therapeutic drug monitoring (e.g., vancomycin) and other acute-care indications; clinical studies and academic collaborations support validation and translation.
Industries
Nr. of Employees
medium (51-250)
Products
Wearable microneedle patch for continuous molecular monitoring
A patch-form wearable that uses microneedles coated with DNA-based electrochemical sensors to continuously measure drug concentrations and biomarkers in interstitial fluid and stream data via Bluetooth.
Wearable microneedle patch for continuous molecular monitoring
A patch-form wearable that uses microneedles coated with DNA-based electrochemical sensors to continuously measure drug concentrations and biomarkers in interstitial fluid and stream data via Bluetooth.
Services
Conducting pilot clinical trials and collaborative translational research with academic and clinical partners to validate wearable biosensor performance.
Rapid prototyping of wearable sensor patches and associated hubs with integrated electronics and wireless data streaming.
Conducting pilot clinical trials and collaborative translational research with academic and clinical partners to validate wearable biosensor performance.
Rapid prototyping of wearable sensor patches and associated hubs with integrated electronics and wireless data streaming.
Expertise Areas
- Continuous molecular monitoring
- Electrochemical aptamer-based biosensing
- Microneedle-enabled wearable diagnostics
- Therapeutic drug monitoring (TDM)
Key Technologies
- Electrochemical aptamer-based sensing (EAB)
- Microneedle sampling and wearable patch design
- Hydrogel protective coatings for sensors
- Bluetooth low-energy telemetry
News & Updates
Peer-reviewed pilot clinical trial reporting continuous drug concentration measurement with a wearable EAB patch.
Publication describing hydrogel microneedle assays for assessing antibiotic treatment.
Publication reporting integration of microneedle and electrochemical sensing for glucose and lactate in live animals.
Awarded Technology Platform Solution of the Year at the AIIA National iAwards.
Company announced raising US$14 million from strategic investors to advance wearable diagnostic platform development.
Participation in a consortium that secured AU$3 million in CRC Projects funding to develop a wearable for sepsis management.
Peer-reviewed pilot clinical trial reporting continuous drug concentration measurement with a wearable EAB patch.
Publication describing hydrogel microneedle assays for assessing antibiotic treatment.
Publication reporting integration of microneedle and electrochemical sensing for glucose and lactate in live animals.
Awarded Technology Platform Solution of the Year at the AIIA National iAwards.
Company announced raising US$14 million from strategic investors to advance wearable diagnostic platform development.
Participation in a consortium that secured AU$3 million in CRC Projects funding to develop a wearable for sepsis management.